The targeted overexpression (or delivery) of Gal-1 should be considered as a method of choice for the treatment of some kinds of inflammation-related diseases, neurodegenerative pathologies and muscular dystrophies.
The targeted overexpression (ordelivery) of Gal-1 should be considered as a method of choicefor the treatment of some kinds of inflammation-relateddiseases, neurodegenerative pathologies and muscular dystrophies.